Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing Enterobacteriaceae

International Journal of Medical Microbiology

Volumn 303, Issue 8, 2013, Pages 553-557

  Gude, MaJose ^a   Seral, Cristina ^a,b   Sáenz, Yolanda ^c   Cebollada, Rocío ^a   González Domínguez, María ^a   Torres, Carmen ^c,d   Castillo, F Javier ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^d UNIVERSITY OF LA RIOJA   (Spain)

Author keywords

Clinical features; CMY 2; Molecular epidemiology; PFGE; Plasmid mediated AmpC; Prevalence

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESCHERICHIA COLI; FEMALE; GENETIC HETEROGENEITY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INVASIVE PROCEDURE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PROTEUS MIRABILIS; URINARY TRACT INFECTION;

CLINICAL FEATURES; CMY-2; MOLECULAR EPIDEMIOLOGY; PFGE; PLASMID-MEDIATED AMPC; PREVALENCE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PLASMIDS;

EID: 84887609793     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.07.007     Document Type: Article

References (31)

1. CTX-M genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005, 49:1319-1322.
2. Baudry P.J., Mataseje L., Zhanel G.G., Hoban D.J., Mulvey M.R. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units. Diagn Microbiol Infect Dis 2009, 65:379-383.
3. Belaaouaj A., Lapoumeroulie C., Canica M.M., Vedel G., Nevot P., Krishnamoorthy R., Paul G. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol Lett 1994, 120:75-80.
4. CLSI, 2010. Clinical and Laboratory Standars Institute. Performance for antimicrobial susceptibility testing: Twentieth Informational Supplement M100-S20.
5. Corvec S., Cremet L., Leprince C., Dauvergne S., Reynaud A., Lepelletier D., Caroff N. Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital. Diagn Microbiol Infect Dis 2010, 67:277-281.
6. Ding H., Yang Y., Lu Q., Wang Y., Chen Y., Deng L., Wang A., Deng Q., Zhang H., Wang C., Liu L., Xu X., Wang L., Shen X. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin Microbiol Infect Dis 2008, 27:915-921.
7. Gude M.J., Seral C., Sáenz Y., González-Domínguez M., Torres C., Castillo F.J. Evaluation of four phenotypic methods to detect plasmid-mediated AmpC beta-lactamases in clinical isolates. Eur J Clin Microbiol Infect Dis 2012, 31:2037-2043.
8. Hanson N.D., Moland E.S., Hong S.G., Propst K., Novak D.J., Cavalieri S.J. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother 2008, 52:3814-3816.
9. Hiroi M., Harada T., Kawamori F., Takahashi N., Kanda T., Sugiyama K., Masuda T., Yoshikawa Y., Ohashi N. A survey of beta-lactamase-producing Escherichia coli in farm animals and raw retail meat in Shizuoka Prefecture, Japan. Jpn J Infect Dis 2011, 64:153-155.
10. Jacoby G.A. AmpC beta-lactamases. Clin Microbiol Rev 2009, 22:161-182.
11. Karczmarczyk M., Abbott Y., Walsh C., Leonard N., Fanning S. Characterization of multidrug-resistant Escherichia coli isolates from animals presenting at a university veterinary hospital. Appl Environ Microbiol 2011, 77:7104-7112.
12. Mata C., Miró E., Rivera A., Mirelis B., Coll P., Navarro F. Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 2010, 16:472-476.
13. Mataseje L.F., Neumann N., Crago B., Baudry P., Zhanel G.G., Louie M., Mulvey M.R. Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006. Antimicrob Agents Chemother 2009, 53:3126-3130.
14. Miró, E., J. Agüero, M. N. Larrosa, A. Fernández, M. C. Conejo, G., Bou, J. J. González-López, N., Lara, L. Martínez-Martínez, A., Oliver, B., Aracil, J., Oteo, A., Pascual, J. Rodríguez-Baño, L. Zamorano and F. Navarro (2013). Prevalence and molecular epidemiology of acquired AmpC beta-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 32, 253-259.
15. Navarro F., Pérez-Trallero E., Marimon J.M., Aliaga R., Gomariz M., Mirelis B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001, 48:383-389.
16. Park Y.S., Adams-Haduch J.M., Shutt K.A., Yarabinec D.M., Johnson L.E., Hingwe A., Lewis J.S., Jorgensen J.H., Doi Y. Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States. Antimicrob Agents Chemother 2012, 56:1870-1876.
17. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
18. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
19. Pitout J.D., Gregson D.B., Church D.L., Laupland K.B. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007, 13:443-448.
20. Pitout J.D., Thomson K.S., Hanson N.D., Ehrhardt A.F., Moland E.S., Sanders C.C. Beta-lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998, 42:1350-1354.
21. Rand K.H., Turner B., Seifert H., Hansen C., Johnson J.A., Zimmer A. Clinical laboratory detection of AmpC beta-lactamase: does it affect patient outcome?. Am J Clin Pathol 2011, 135:572-576.
22. Rodríguez-Baño J., Miró E., Villar M., Coelho A., Gozalo M., Borrell N., Bou G., Conejo M.C., Pomar V., Aracil B., Larrosa N., Aguero J., Oliver A., Fernández A., Oteo J., Pascual A., Navarro F. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC beta-lactamases. J Infect 2012, 64:176-183.
23. Seral C., Gude M.J., Castillo F.J. Emergence of plasmid mediated AmpC beta-lactamasas: origin, importance, detection and therapeutical options. Rev Esp Quimioter 2012, 25:89-99.
24. Sidjabat H.E., Paterson D.L., Qureshi Z.A., Adams-Haduch J.M., O'Keefe A., Pascual A., Rodríguez-Baño J., Doi Y. Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. Clin Infect Dis 2009, 48:739-744.
25. Simner P.J., Zhanel G.G., Pitout J., Tailor F., McCracken M., Mulvey M.R., Lagace-Wiens P.R., Adam H.J., Hoban D.J. Prevalence and characterization of extended-spectrum beta-lactamase- and AmpC beta-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011, 69:326-334.
26. Singtohin S., Chanawong A., Lulitanond A., Sribenjalux P., Auncharoen A., Kaewkes W., Songsri J., Pienthaweechai K. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagn Microbiol Infect Dis 2010, 68:271-277.
27. Song W., Kim J.S., Kim H.S., Yong D., Jeong S.H., Park M.J., Lee K.M. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006, 55:219-224.
28. Steward C.D., Rasheed J.K., Hubert S.K., Biddle J.W., Raney P.M., Anderson G.J., Williams P.P., Brittain K.L., Oliver A., McGowan J.E., Tenover F.C. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods. J Clin Microbiol 2001, 39:2864-2872.
29. Tamang M.D., Nam H.M., Jang G.C., Kim S.R., Chae M.H., Jung S.C., Byun J.W., Park Y.H., Lim S.K. Molecular characterization of extended-spectrum beta-lactamase and plasmid mediated AmpC beta-lactamase-producing Escherichia coli isolated from stray dogs from Korea. Antimicrob Agents Chemother 2012, 56:2705-2712.
30. Yamasaki K., Komatsu M., Abe N., Fukuda S., Miyamoto Y., Higuchi T., Ono T., Nishio H., Sueyoshi N., Kida K., Satoh K., Toyokawa M., Nishi I., Sakamoto M., Akagi M., Nakai I., Kofuku T., Orita T., Wada Y., Jikimoto T., Kinoshita S., Miyamoto K., Hirai I., Yamamoto Y. Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan. J Clin Microbiol 2010, 48:3267-3273.
31. Yum J.H., Kim S., Lee H., Yong D., Lee K., Cho S.N., Chong Y. Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC beta-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J Korean Med Sci 2005, 20:961-965.